Citigroup’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.6M Sell
210,320
-173,507
-45% -$2.97M ﹤0.01% 1632
2025
Q1
$24.5M Buy
383,827
+309,732
+418% +$19.8M 0.01% 618
2024
Q4
$9.01M Buy
74,095
+17,335
+31% +$2.11M 0.01% 1019
2024
Q3
$7.09M Buy
56,760
+24,594
+76% +$3.07M ﹤0.01% 1105
2024
Q2
$5.08M Sell
32,166
-48,085
-60% -$7.6M ﹤0.01% 1167
2024
Q1
$10.4M Buy
80,251
+14,865
+23% +$1.92M 0.01% 883
2023
Q4
$6.31M Buy
65,386
+19,704
+43% +$1.9M ﹤0.01% 1016
2023
Q3
$5.54M Buy
45,682
+1,939
+4% +$235K ﹤0.01% 993
2023
Q2
$5.01M Sell
43,743
-37,277
-46% -$4.27M ﹤0.01% 1089
2023
Q1
$11.2M Buy
81,020
+44,517
+122% +$6.14M 0.01% 810
2022
Q4
$4.73M Sell
36,503
-29,207
-44% -$3.78M ﹤0.01% 1086
2022
Q3
$7.26M Sell
65,710
-29,556
-31% -$3.27M 0.01% 935
2022
Q2
$7.14M Buy
95,266
+44,525
+88% +$3.34M 0.01% 956
2022
Q1
$3.96M Sell
50,741
-31,769
-39% -$2.48M ﹤0.01% 1302
2021
Q4
$7.43M Buy
82,510
+26,313
+47% +$2.37M ﹤0.01% 1078
2021
Q3
$5.2M Sell
56,197
-80,125
-59% -$7.41M ﹤0.01% 1291
2021
Q2
$10.6M Buy
136,322
+41,936
+44% +$3.26M 0.01% 1014
2021
Q1
$7.04M Buy
94,386
+56,315
+148% +$4.2M ﹤0.01% 1175
2020
Q4
$6.49M Sell
38,071
-2,078
-5% -$354K ﹤0.01% 1146
2020
Q3
$5.64M Sell
40,149
-13,836
-26% -$1.94M ﹤0.01% 1079
2020
Q2
$8.66M Buy
53,985
+1,055
+2% +$169K 0.01% 841
2020
Q1
$5.18M Sell
52,930
-24,813
-32% -$2.43M ﹤0.01% 919
2019
Q4
$10M Sell
77,743
-1,697
-2% -$219K 0.01% 859
2019
Q3
$5.98M Sell
79,440
-145,765
-65% -$11M ﹤0.01% 996
2019
Q2
$34.2M Buy
225,205
+132,580
+143% +$20.1M 0.03% 376
2019
Q1
$11M Buy
92,625
+7,973
+9% +$950K 0.01% 679
2018
Q4
$9.24M Buy
84,652
+30,847
+57% +$3.37M 0.01% 734
2018
Q3
$8.69M Buy
53,805
+34,894
+185% +$5.64M 0.01% 758
2018
Q2
$2.5M Sell
18,911
-77,302
-80% -$10.2M ﹤0.01% 1369
2018
Q1
$7.13M Sell
96,213
-47,809
-33% -$3.54M 0.01% 827
2017
Q4
$8.01M Buy
144,022
+100,771
+233% +$5.61M 0.01% 770
2017
Q3
$1.96M Sell
43,251
-88,443
-67% -$4.01M ﹤0.01% 1506
2017
Q2
$4.44M Buy
131,694
+62,383
+90% +$2.1M ﹤0.01% 1008
2017
Q1
$2.05M Buy
69,311
+41,476
+149% +$1.23M ﹤0.01% 1407
2016
Q4
$763K Sell
27,835
-1,020
-4% -$28K ﹤0.01% 2588
2016
Q3
$1.77M Sell
28,855
-3,634
-11% -$223K ﹤0.01% 1484
2016
Q2
$619K Sell
32,489
-50,735
-61% -$967K ﹤0.01% 2026
2016
Q1
$1.62M Buy
83,224
+41,359
+99% +$807K ﹤0.01% 1625
2015
Q4
$1.62M Buy
41,865
+12,906
+45% +$498K ﹤0.01% 1458
2015
Q3
$929K Buy
28,959
+6,658
+30% +$214K ﹤0.01% 1778
2015
Q2
$679K Buy
22,301
+8,306
+59% +$253K ﹤0.01% 1941
2015
Q1
$186K Sell
13,995
-6,206
-31% -$82.5K ﹤0.01% 3012
2014
Q4
$293K Buy
20,201
+15,420
+323% +$224K ﹤0.01% 2879
2014
Q3
$101K Sell
4,781
-3,269
-41% -$69.1K ﹤0.01% 3140
2014
Q2
$240K Sell
8,050
-6,749
-46% -$201K ﹤0.01% 2438
2014
Q1
$356K Sell
14,799
-13,352
-47% -$321K ﹤0.01% 2387
2013
Q4
$573K Buy
28,151
+17,657
+168% +$359K ﹤0.01% 2260
2013
Q3
$495K Sell
10,494
-337
-3% -$15.9K ﹤0.01% 1984
2013
Q2
$412K Buy
+10,831
New +$412K ﹤0.01% 2204